Direct comparison
Cell Dissociation Reagents Compared
Compare trypsin, recombinant (TrypLE/Accutase-type), collagenase/dispase, and non-enzymatic dissociation reagents on mechanism, epitope impact, and sourcing.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · free to try
Ask about Cell Dissociation Reagents Compared
Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.
An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do Porcine trypsin (crude/purified), Recombinant, animal-origin-free (TrypLE-/Accutase-type), Collagenase / dispase blends, Non-enzymatic (EDTA/chelation) compare side by side?
The table below compares Porcine trypsin (crude/purified), Recombinant, animal-origin-free (TrypLE-/Accutase-type), Collagenase / dispase blends, Non-enzymatic (EDTA/chelation) across 9 procurement-relevant dimensions, from mechanism through when to avoid.
Side-by-side comparison
| Dimension | Porcine trypsin (crude/purified) | Recombinant, animal-origin-free (TrypLE-/Accutase-type) | Collagenase / dispase blends | Non-enzymatic (EDTA/chelation) |
|---|---|---|---|---|
| Mechanism | Serine protease cleaves cell-surface and matrix proteins non-specifically to break cell-substrate and cell-cell adhesion | Recombinant serine protease (or protease blend) engineered/produced for trypsin-like activity without animal sourcing | Cleaves collagen and other ECM proteins directly; often blended with a neutral protease (dispase) to also loosen cell-cell junctions | Chelates divalent cations (Ca2+/Mg2+) that cadherins and other adhesion proteins require, weakening junctions without proteolysis |
| Typical use case | Routine passaging of robust adherent lines (e.g., many immortalized monolayer cultures) where surface-epitope integrity is not critical | Flow cytometry, cell sorting, single-cell workflows, and any downstream step where surface-marker or receptor integrity matters | Primary tissue dissociation, organoids, tumor or ECM-rich samples where trypsin alone under-digests the matrix | Gentle passaging of loosely adherent or fragile lines, or short-term detachment immediately before an assay sensitive to any proteolysis |
| Effect on surface epitopes/receptors | Can cleave surface receptors and some antibody epitopes — a known confound in downstream flow cytometry or receptor-binding assays | Formulated to be gentler on common surface markers than crude trypsin, though not epitope-neutral — verify against the specific marker panel | Targets matrix rather than surface protein directly, but dispase components can still affect some receptors | Minimal proteolytic epitope disruption — the reason it is preferred immediately before antibody-based assays where trypsin would confound results |
| Animal-origin-free availability | Porcine-derived by default; animal-origin-free versions exist but are a separate SKU, not the standard product | Animal-origin-free by design — this is the primary reason the category exists for cell-therapy-adjacent and xeno-free workflows | Historically bacterial-fermentation-derived (Clostridium) but formulation/purification can still carry animal-derived components — confirm sourcing per lot | Chelator-based formulations are typically animal-component-free, but confirm the full buffer/media base is also xeno-free if that matters for the application |
| Grade tiers available | Research-grade is standard; USP <1043>-referenced GMP grades exist for cell/gene therapy manufacturing but at a materially higher price point | Available across research-grade through GMP grades manufactured under quality systems referencing USP <1043> ancillary-material guidance | Predominantly research-grade; GMP-grade collagenase/dispase blends are a narrower, higher-cost market than GMP trypsin alternatives | Predominantly research-grade; less commonly manufactured to GMP ancillary-material specifications |
| Documentation to request from a supplier | Certificate of Analysis (activity units, sterility), lot-to-lot activity consistency data; endotoxin/mycoplasma testing if used near cell-therapy work | Certificate of Analysis, animal-origin-free/xeno-free declaration, endotoxin and mycoplasma test results, and — for GMP SKUs — a Drug Master File reference or equivalent regulatory support file | Certificate of Analysis with specific activity (units/mg), source organism/strain, endotoxin level, and lot-specific enzyme-ratio data (collagenase:dispase varies lot to lot and affects digestion consistency) | Certificate of Analysis (sterility, endotoxin if relevant), formulation/buffer composition, and stability data |
| Storage & shelf-life considerations | Typically frozen aliquots or refrigerated ready-to-use solutions; activity degrades with freeze-thaw cycling — single-use aliquoting is standard practice | Similar cold-chain handling to trypsin; check manufacturer freeze-thaw stability data before adopting a multi-use aliquot policy | More freeze-thaw-sensitive than trypsin in practice — lot-specific activity loss is a common cause of inconsistent primary-tissue digestion | Generally more stable at 4C with a longer working shelf life since there is no enzyme activity to preserve |
| Relative cost tier | Lowest cost per use for research-grade material | Moderate to high — premium over crude trypsin for animal-origin-free sourcing and documentation | Moderate to high, with meaningful lot-to-lot activity variability driving effective cost through repeat/failed digestions | Moderate — comparable to or above standard trypsin depending on formulation |
| When to avoid | Avoid where surface-marker integrity is assay-critical, or where an animal-origin-free supply chain is a stated requirement | Rarely a wrong choice on biology grounds; the main constraint is budget and, for GMP tiers, lead time | Avoid for routine monolayer passaging where a simpler, cheaper reagent achieves the same result | Avoid for tightly-junctioned or ECM-dense tissue — it will under-dissociate and yield poor single-cell suspensions |
Common questions
Common questions about Porcine trypsin (crude/purified) vs Recombinant, animal-origin-free (TrypLE-/Accutase-type) vs Collagenase / dispase blends vs Non-enzymatic (EDTA/chelation)
What is the actual difference between trypsin and Accutase-type recombinant reagents?
+
Both are proteases that break down cell-surface and matrix adhesion proteins to release cells from a substrate or from each other. The practical differences are sourcing (porcine-derived trypsin vs. recombinant, animal-origin-free production) and gentleness — recombinant, animal-origin-free formulations are generally marketed and used where surface-epitope preservation for downstream flow cytometry or antibody-based assays matters more than raw cost.
Do I need animal-origin-free (AOF) dissociation reagents for my work?
+
It depends on downstream use, not on general caution. Cell-therapy and other regulated cell/gene-therapy manufacturing contexts typically require ancillary materials — including dissociation enzymes — to be sourced and documented in line with GMP quality-system expectations, for which USP General Chapter <1043> on Ancillary Materials for Cell, Gene, and Tissue-Engineered Products is a widely referenced framework. Routine research-only workflows generally do not require AOF sourcing unless a specific protocol, funder, or downstream regulatory pathway calls for it — check your protocol and institutional biosafety/quality requirements before defaulting to the more expensive tier.
What should I ask a supplier for before adding a dissociation reagent to a standing order?
+
At minimum: a Certificate of Analysis for the specific lot (enzyme activity or specific activity, sterility, endotoxin level where relevant), a statement of animal-origin status, and evidence of lot-to-lot consistency testing — particularly for collagenase/dispase blends, where enzyme-ratio variability between lots is a well-known cause of inconsistent tissue digestion. For GMP-grade material intended for cell/gene therapy manufacturing, also request the regulatory support documentation (e.g., a Drug Master File reference) the manufacturer maintains for that product.
Why does collagenase/dispase lot variability matter for procurement?
+
Collagenase is typically produced by bacterial fermentation and purified as a blend of several proteolytic activities alongside dispase; the ratio of these activities can shift between production lots even within the same catalog number. For primary-tissue or organoid work where digestion consistency drives yield and viability, it is standard practice to request lot-specific activity data and, where budget allows, to qualify and reserve a preferred lot rather than accepting whatever ships next.
Can dissociation reagents be substituted for one another without changing the protocol?
+
Not safely. Switching from trypsin to a non-enzymatic chelator, or from a generic recombinant enzyme to a different formulation, changes dissociation kinetics and can change cell viability, yield, and surface-marker integrity. Treat a reagent-class change as a protocol change requiring its own qualification run, not a like-for-like vendor swap.
Going deeper
